Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/5153
Title: H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease
Authors: Lenzi, Cristina
Palazzuoli, Alberto
Giordano, NICOLA GIUSEPPE
Alegente, G
Gonnelli, Catia
Campagna, MARIA STELLA
Santucci, Annalisa 
Sozzi, M
Papakostas, Panagiotis
Rollo, Fabio
Nuti, Ranuccio
Figura, Natale
Keywords: H pylori; coronary heart disease; CagA protein; heat shock protein 60; antibody response
Issue Date: 2006
Project: None 
Journal: WORLD JOURNAL OF GASTROENTEROLOGY
Abstract: 
AIM: to determine the overall prevalence of H pylori and CagA positive H pylori infection and the prevalence of other bacterial and viral causes of chronic infection in patients with coronary heart disease (CHD), and the potential role of anti-heat-shock protein 60 (Hsp60) antibody response to these proteins in increasing the risk of CHD development. METHODS: Eighty patients with CHD and 160 controls were employed. We also compared the levels of anti-heat-shock protein 60 (Hsp60) antibodies in the two groups. The H pylori infection and the CagA status were determined serologically, using commercially available enzyme-linked immunosorbent assays (ELISA), and a Western blotting method developed in our laboratory. Systemic antibodies to Hsp60 were determined by a sandwich ELISA, using a polyclonal antibody to Hsp60 to sensitise polystyrene plates and a commercially available human Hsp60 as an antigen. RESULTS: The overall prevalence of H pylori infection was 78.7% (n = 63) in patients and 76.2% (n = 122) in controls (P = 0.07). Patients infected by CagA-positive (CagA+) H pylori strains were 71.4% (n = 45) vs 52.4% of infected controls (P = 0.030, OR = 2.27). Systemic levels of IgG to Hsp60 were increased in H pylori-negative patients compared with uninfected controls (P < 0.001) and CagA-positive infected patients compared with CagA-positive infected controls (P = 0.007). CONCLUSION: CagA positive H pylori infection may concur to the development of CHD; high levels of anti-Hsp60 antibodies may constitute a marker and/or a concomitant pathogenic factor of the disease.
Description: 
37546
URI: http://hdl.handle.net/20.500.12779/5153
ISSN: 1007-9327
DOI: 10.3748/wjg.v12.i48.7815
Appears in Collections:Publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.